Resources for Journalists

COVID-19 is a disease caused by the SARS-CoV-2 virus strain, that has not been previously identified in humans. See below for a collection of resources to help you cover this issue (Please note: additional resources are available to journalists who are logged in).

The AusSMC also issues a daily COVID-19 update for registered journalists (click here to view an example). If you would like to receive this email, please go to your profile on MyScimex and select yes beside "Receive COVID-19 Updates?". The email update and this resources page are supported by the Google News Initiative.

Latest COVID-19 news, research, expert reactions and briefings

Show/Hide newsfeed filter Filter by
Type
News for

Choose a location of interest

  1. Kids may be more likely to develop long COVID after a second infection

    Publicly released: Wed 1 Oct 2025 at 0830 AEST, 1130 NZDT

    The Lancet Infectious Diseases

    Researchers compared health outcomes following children’s first and second documented COVID-19 infections to isolate the risks associated with reinfection. ... They say the study’s findings reinforce Read more about Kids may be more likely to develop long COVID after a second infection

    InternationalUniversity of Pennsylvania, USA

  2. Popular type of yoga linked to higher rates of falls among older Australians

    Publicly released: Tue 30 Sep 2025 at 1616 AEST, 1916 NZDT

    Lancet Healthy Longevity

    Carrying out the studyThe research team recruited 700 people aged 60 and over who did not currently practise yoga. ... to run the classes in person but, because the study took place during COVID-19, we Read more about Popular type of yoga linked to higher rates of falls among older Australians

    Australia; NSWThe University of Sydney | The University of New South Wales ...

  3. Switch to 2-in-1 inhalers reduces children's asthma attacks

    Publicly released: Sun 28 Sep 2025 at 1500 AEST, 1800 NZDT

    The Lancet

    However, the authors acknowledge some limitations of the clinical trial. It was undertaken during the COVID-19 pandemic, during which stringent public health measures and fewer circulating Read more about Switch to 2-in-1 inhalers reduces children's asthma attacks

    New ZealandMedical Research Institute of New Zealand

  4. Low-cost drug shows promise for patients with life-threatening respiratory infections

    Publicly released: Sun 28 Sep 2025 at 0930 AEST, 1230 NZDT

    eClinicalMedicine

    A widely available and affordable drug has shown to be effective in treating seriously ill COVID-19 patients, according to a new study from The Australian National University (ANU). ... We know it’s Read more about Low-cost drug shows promise for patients with life-threatening respiratory infections

    Australia; VIC; ACTThe Australian National University | Monash University

  5. Coordinated action needed to reverse Australia’s declining childhood vaccination rates

    Publicly released: Fri 26 Sep 2025 at 0001 AEST, 0201 NZST

    Australian and New Zealand Journal of Public Health

    Childhood vaccination rates have declined each year since the start of the COVID-19 pandemic. ... The power and reach of social media, the challenges raised by COVID-19 and misinformation around Read more about Coordinated action needed to reverse Australia’s declining childhood vaccination rates

    Australia; NSW; VICNational Centre for Immunisation Research and Surveillance (NCIRS) ...

  6. Unlocking the immune system’s instruction manual

    Publicly released: Wed 24 Sep 2025 at 1030 AEST, 1230 NZST

    Nature Immunology

    These tissues included tonsil, adenoid and blood from multiple cohorts, allowing researchers to track Tfh cells across different tissue types and timepoints – including during COVID infection and Read more about Unlocking the immune system’s instruction manual

    Australia; NSW; VIC; QLD; SA; TASWEHI | The University of Melbourne | The University of Queensland ...

  7. Pioneering the next-generation ‘nano’ drug delivery system

    Publicly released: Tue 23 Sep 2025 at 0927 AEST, 1127 NZST

    Advanced Materials

    LNPs are best known as the delivery vehicles that enabled the Pfizer–BioNTech and Moderna COVID-19 vaccines, protecting fragile mRNA molecules and ensuring they reach target cells. ... Their success Read more about Pioneering the next-generation ‘nano’ drug delivery system

    Australia; VICThe University of Melbourne | Olivia Newton-John Cancer Research Institute ...

  8. Over 4 million more people would be alive in 2025 if they had got adequate type 1 diabetes care

    Publicly released: Fri 19 Sep 2025 at 0801 AEST, 1001 NZST

    The European Association for the Study of Diabetes (EASD)

    of The European Association for the Study of Diabetes (EASD), Vienna (15-19 Sept). ... Furthermore, incidence data from the COVID-19 period were excluded from part of the modelling to avoid bias. Read more about Over 4 million more people would be alive in 2025 if they had got adequate type 1 diabetes care

    InternationalBreakthrough T1D, USA

  9. COVID made training inequities worse for female surgeons

    Publicly released: Fri 19 Sep 2025 at 0001 AEST, 0201 NZST

    New Zealand Medical Journal

    Researchers found that male trainee surgeons were already doing more surgeries than females before COVID, but that this difference got even worse during the pandemic. ... Gender disparity and the impact Read more about COVID made training inequities worse for female surgeons

    New ZealandWaikato DHB Hospital, NZ

  10. EXPERT REACTION: US vaccine panel meeting to consider safety of COVID-19 and other vaccines

    Publicly released: Thu 18 Sep 2025 at 1030 AEST, 1230 NZST

    The draft agenda shows that they will be discussing the measles, mumps, rubella, and varicella (MMRV) vaccine and hepatitis B vaccine on Thursday, and the COVID-19 vaccines on Friday. ... Below, Read more about EXPERT REACTION: US vaccine panel meeting to consider safety of COVID-19 and other vaccines

    Australia; NSW; QLD; WAAustralian Science Media Centre

Show Results

  1. 10
  2. 20
  3. 50